NCT03384238 2026-03-17
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Stanford University
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT05973331 2026-02-09
Prospective Validation of an EHR-based Pancreatic Cancer Risk Model
Beth Israel Deaconess Medical Center
Active not recruiting
NCT02336087 2026-02-04
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
City of Hope Medical Center
Phase 1 Active not recruiting
NCT06760234 2026-01-07
Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed